| 000 | 01885 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516115916.0 | ||
| 264 | 0 | _c20130530 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1573-7209 | ||
| 024 | 7 |
_a10.1007/s10456-012-9314-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReichenbach, Gabi | |
| 245 | 0 | 0 |
_aPPARĪ± agonist Wy14643 suppresses cathepsin B in human endothelial cells via transcriptional, post-transcriptional and post-translational mechanisms. _h[electronic resource] |
| 260 |
_bAngiogenesis _cJan 2013 |
||
| 300 |
_a223-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlternative Splicing _xdrug effects |
| 650 | 0 | 4 |
_aBase Pairing _xgenetics |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCathepsin B _xgenetics |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aE-Box Elements _xgenetics |
| 650 | 0 | 4 |
_aExons _xgenetics |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 |
_aHuman Umbilical Vein Endothelial Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPPAR alpha _xagonists |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 |
_aProtein Binding _xdrug effects |
| 650 | 0 | 4 |
_aProtein Processing, Post-Translational _xdrug effects |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 |
_aSubcellular Fractions _xdrug effects |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 |
_aUpstream Stimulatory Factors _xmetabolism |
| 700 | 1 | _aStarzinski-Powitz, Anna | |
| 700 | 1 | _aSloane, Bonnie F | |
| 700 | 1 | _aDoll, Monika | |
| 700 | 1 | _aKippenberger, Stefan | |
| 700 | 1 | _aBernd, August | |
| 700 | 1 | _aKaufmann, Roland | |
| 700 | 1 | _aMeissner, Markus | |
| 773 | 0 |
_tAngiogenesis _gvol. 16 _gno. 1 _gp. 223-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10456-012-9314-9 _zAvailable from publisher's website |
| 999 |
_c22211533 _d22211533 |
||